Designing and optimizing an intelligent health informatics management platform for patients undergoing chemotherapy for breast cancer: from needs assessment to pilot testing
4 affiliations
- 1Department of Nursing, Affiliated Hospital of Zunyi Medical University
- 2School of Nursing, Zunyi Medical University
- 3Information Department, Affiliated Hospital of Zunyi Medical University
- 4School of Medical Information Engineering, Zunyi Medical University
Abstract
Objective: To design and optimize a health informatics management platform embedded in an official WeChat public account—a widely used social media and messaging application in China—to support chemotherapy-induced myelosuppression (CIM) management and patient self-management among breast cancer patients undergoing chemotherapy.
Methods: Guided by a user-centered design approach, the platform was developed and refined in three stages: needs assessment, expert review and iterative refinement, and pilot feasibility testing.
Results: Most patients (88.6%) and clinicians (93.9%) recognized the need for such a platform. In the pilot evaluation, the mean overall MAUQ score was 3.63 ± 0.32, suggesting moderate usability and room for further refinement. During pilot testing, the alert system generated 11 CIM-related alerts and delivered corresponding risk-stratified guidance.
Conclusions: The platform may support personalized CIM management by enabling remote monitoring, automated alerts, and risk-stratified guidance. Further studies with larger samples and longer follow-up are needed to evaluate its effectiveness in improving patient self-management and clinical follow-up efficiency.
Related
- Anesthetic management of a child undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent embryonal rhabdomyosarcoma: A case report.
- Fear of progression as a mediator between symptom burden and social alienation in lung cancer patients undergoing chemotherapy
- A Novel Informatics-Driven Model for Proactive Radiation Safety Management: Lessons from a Tumor Specialist Hospital in China.
- Prognostic value of the neutrophil-to-lymphocyte ratio in patients with colorectal cancer undergoing chemotherapy: a systematic review and meta-analysis
- Effect of Danggui Buxue Medicinal Diet on cancer-related fatigue in anemic colon cancer patients undergoing chemotherapy : A randomized controlled trial (CONSORT-compliant)
BibTeX
@article{yu2026designing,
title = {{Designing and optimizing an intelligent health informatics management platform for patients undergoing chemotherapy for breast cancer: from needs assessment to pilot testing}},
author = {Xiaosong Yu and Lin Zhang and Li Yang and Shaolin Chen and Xiaohua Wang},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1865670},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1865670/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Designing and optimizing an intelligent health informatics management platform for patients undergoing chemotherapy for breast cancer: from needs assessment to pilot testing
AU - Xiaosong Yu
AU - Lin Zhang
AU - Li Yang
AU - Shaolin Chen
AU - Xiaohua Wang
PY - 2026
DA - 2026/10/22
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1865670
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1865670/full
AB - Objective: To design and optimize a health informatics management platform embedded in an official WeChat public account—a widely used social media and messaging application in China—to support chemotherapy-induced myelosuppression (CIM) management and patient self-management among breast cancer patients undergoing chemotherapy. Methods: Guided by a user-centered design approach, the platform was developed and refined in three stages: needs assessment, expert review and iterative refinement, and pilot feasibility testing. Results: Most patients (88.6%) and clinicians (93.9%) recognized the need for such a platform. In the pilot evaluation, the mean overall MAUQ score was 3.63 ± 0.32, suggesting moderate usability and room for further refinement. During pilot testing, the alert system generated 11 CIM-related alerts and delivered corresponding risk-stratified guidance. Conclusions: The platform may support personalized CIM management by enabling remote monitoring, automated alerts, and risk-stratified guidance. Further studies with larger samples and longer follow-up are needed to evaluate its effectiveness in improving patient self-management and clinical follow-up efficiency.
SN - 2234-943X
ER -